back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Szela, Mary
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
36 - Conversion or exchange
|
-6,632 vol |
184,924 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Szela, Mary
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-21,176.16
-2,248 vol $9.42 each |
4,384 | |
| Filed 2017-05-11 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Szela, Mary
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Szela, Mary
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+6,632 vol |
6,632 | |
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Szela, Mary
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
56 - Grant of rights
|
+171,660 vol |
191,556 | |
| Filed 2016-12-27 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Szela, Mary
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Szela, Mary
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+323,520 vol |
323,520 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Szela, Mary
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
37 - Stock split or consolidation
|
-79,587 vol |
19,896 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Szela, Mary
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Szela, Mary
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+99,483 vol |
99,483 |